Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation
- PMID: 8197126
- PMCID: PMC43862
- DOI: 10.1073/pnas.91.11.4731
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation
Abstract
The met protooncogene product, Met, is the tyrosine kinase growth factor receptor for hepatocyte growth factor/scatter factor (HGF/SF). NIH 3T3 cells express HGF/SF endogenously and become tumorigenic in nude mice via an autocrine mechanism when murine Met is expressed ectopically (Metmu cells) or when human Met and human HGF/SF are coexpressed (HMH cells). Here, we show that Metmu and HMH cells are invasive in vitro and display enhanced protease activity necessary for the invasive phenotype. In experimental and spontaneous metastasis assays, Metmu or HMH cells metastasize to the lung, but lower numbers of subcutaneously injected Metmu and HMH cells produced invasive tumors in the heart, diaphragm, salivary gland, and retroperitoneum. It has been reported elsewhere that Met expression increased with tumor passage in athymic nude mice, and these tumor explants show enhanced activity in the metastasis assays. Autocrine-mediated Met-HGF/SF signal transduction in NIH 3T3 mesenchymal cells may provide an important system for understanding the biological process of metastasis.
Similar articles
-
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.Mol Cell Biol. 1992 Nov;12(11):5152-8. doi: 10.1128/mcb.12.11.5152-5158.1992. Mol Cell Biol. 1992. PMID: 1406687 Free PMC article.
-
Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.Oncogene. 1996 Aug 15;13(4):853-6. Oncogene. 1996. PMID: 8761307
-
The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis.EXS. 1995;74:89-121. doi: 10.1007/978-3-0348-9070-0_6. EXS. 1995. PMID: 8527903 Review.
-
Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.Cell Growth Differ. 1993 Jul;4(7):563-9. Cell Growth Differ. 1993. PMID: 8398896
-
Met-HGF/SF: tumorigenesis, invasion and metastasis.Ciba Found Symp. 1997;212:119-30; discussion 130-2, 148-54. doi: 10.1002/9780470515457.ch8. Ciba Found Symp. 1997. PMID: 9524767 Review.
Cited by
-
Targeting MET in cancer: rationale and progress.Nat Rev Cancer. 2012 Jan 24;12(2):89-103. doi: 10.1038/nrc3205. Nat Rev Cancer. 2012. PMID: 22270953 Review.
-
Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w. Signal Transduct Target Ther. 2024. PMID: 39138146 Free PMC article. Review.
-
Prognostic and predictive value of MET deregulation in non-small cell lung cancer.Ann Transl Med. 2015 Apr;3(6):83. doi: 10.3978/j.issn.2305-5839.2015.03.43. Ann Transl Med. 2015. PMID: 25992382 Free PMC article. Review.
-
Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans.J Exp Med. 2000 Oct 16;192(8):1115-24. doi: 10.1084/jem.192.8.1115. J Exp Med. 2000. PMID: 11034601 Free PMC article.
-
Role of cancer cell-stroma interaction in invasive growth of cancer cells.Hum Cell. 2003 Mar;16(1):1-14. doi: 10.1111/j.1749-0774.2003.tb00123.x. Hum Cell. 2003. PMID: 12971620 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous